TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/22 08:55 | 11/1/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 116 | 8 | 1,542 | D | ||||||||||||||
5/6/22 18:04 | 5/5/22 | IFF | International Flavors & Fragrances Inc | NY | Chem | OChm | Industrial Organic Chemicals | Schultz Kare | NY | D | M.d | 0 | 0.00 | 0 | 1 | 427 | 1 | D | |||||||||||||||
3/8/22 16:12 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.dm | 0 | 0.00 | 0 | 294 | 26 | 1,426 | D | ||||||||||||||
3/2/22 07:51 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 65 | 6 | 1,132 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |